相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-Term Outcomes of Behcet's Syndrome-Related Uveitis: A Monocentric Italian Experience
Jurgen Sota et al.
MEDIATORS OF INFLAMMATION (2020)
Demonstration of functional similarity of a biosimilar adalimumab SB5 to Humira®
JongAh Joanne Lee et al.
BIOLOGICALS (2019)
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies
Claudia Fabiani et al.
CLINICAL RHEUMATOLOGY (2018)
Behcet syndrome: a contemporary view
Hasan Yazici et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
Biosimilar switching and related medical liability
Paolo Rocco et al.
JOURNAL OF FORENSIC AND LEGAL MEDICINE (2018)
Biologics are too complicated to duplicate: should we be worried about biosimilars?
A. Cline et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Cumulative retention rate of adalimumab in patients with Behcet's disease-related uveitis: a four-year follow-up study
Claudia Fabiani et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2018)
Efficacy and safety of adalimumab in Beh‡et's disease-related uveitis: a multicenter retrospective observational study
Claudia Fabiani et al.
CLINICAL RHEUMATOLOGY (2017)
Quality of life impairment in Beh‡et's disease and relationship with disease activity: a prospective study
Claudia Fabiani et al.
INTERNAL AND EMERGENCY MEDICINE (2017)
Is Extrapolation of the Safety and Efficacy Data in One Indication to Another Appropriate for Biosimilars?
Howard Lee
AAPS JOURNAL (2014)
Expert Panel Recommendations for the Use of Anti-Tumor Necrosis Factor Biologic Agents in Patients with Ocular Inflammatory Disorders
Grace Levy-Clarke et al.
OPHTHALMOLOGY (2014)
Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop
DA Jabs et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2005)
The long-term mortality and morbidity of Behcet syndrome - A 2-decade outcome survey of 387 patients followed at a dedicated center
E Kural-Seyahi et al.
MEDICINE (2003)
分享论文
